Kalyan Shastri
Neurology · Buffalo, NYNPI 1275794554
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.5% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 16.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,173 and has fallen 94.4% since, to $66 in 2022.
Across 92 payments — averaging $16.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$263
- Amgen$140
- Teva Pharmaceuticals USA, Inc.$130
- AbbVie$97
- Novartis$94
- Acorda Therapeutics, Inc$86
- plus $749 from 21 others
What the payments were for
- Speaking & faculty fees$865%
- Food & beverage$1,47295%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 13 | $263 |
| Amgen | 9 | $140 |
| Teva Pharmaceuticals USA, Inc. | 7 | $130 |
| AbbVie(2 entities) | 6 | $97 |
| Novartis | 5 | $94 |
| Acorda Therapeutics, Inc | 4 | $86 |
| Assertio Therapeutics, Inc. | 5 | $77 |
| Supernus Pharmaceuticals, Inc. | 5 | $75 |
| Livanova USA, Inc. | 4 | $64 |
| Acadia Pharmaceuticals Inc | 4 | $59 |
| Biogen | 3 | $55 |
| Promius Pharma LLC | 4 | $52 |
| Upsher-smith Laboratories LLC | 3 | $49 |
| Neurocrine Biosciences, Inc. | 2 | $44 |
| Eisai Inc. | 2 | $33 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Bayer | 2 | $28 |
| Amneal Pharmaceuticals LLC | 2 | $27 |
| Adamas Pharmaceuticals, Inc. | 2 | $24 |
| Boston Scientific | 1 | $23 |
| Harmony Biosciences LLC | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $15 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $13 |
| Vertical Pharmaceuticals, LLC | 1 | $12 |
How this compares
$1,558 in reported general payments places this provider in the 55th percentile of 1,623 neurology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levetiracetam | 30 | $997 |
Paid to pharmacies, not to this prescriber.
Other neurology in Buffalo
- Gil WolfeBuffalo$617K
- David HojnackiBuffalo$480K
- Bianca Weinstock GuttmanBuffalo$288K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.